Global Pandemic Conditions and List of Possible Medications and Vaccines for the Treatment of COVID-19: A Review
Open Access
- 22 June 2020
- journal article
- review article
- Published by Universitas Muhammadiyah Palangkaraya in Borneo Journal of Pharmacy
- Vol. 3 (Special-1), 90-102
- https://doi.org/10.33084/bjop.v3ispecial-1.1397
Abstract
At the end of December 2019, a novel coronavirus was identified which caused severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with a disease known as coronavirus disease 2019 (COVID-19). The virus first originated in the city of Wuhan in China, causing symptoms such as pneumonic plague, which began in the Wuhan and then spread throughout the world with high transmission efficiency. Special precautions and care are needed such as leaving the public area, covering your mouth with a mask, not shaking hands, washing hands, and sanitation from time to time. Infection due to SARS-CoV-2 shows several symptoms, one of which is very often the patient shows difficulty breathing. Currently, COVID-19 has been declared a global pandemic and has almost attacked all countries in the world, including in India which has one of the largest human populations in the entire world. One of the challenges in handling COVID-19 is the unavailability of drugs or special vaccines to treat the disease, so clinical practitioners and academics are currently testing various drugs to see how they affect the COVID-19 patients. Some of the drugs tested provide effective mechanisms against SARS-CoV-2, such as chloroquine, remdesivir, lopinavir, and vaccines under development. These drugs are still being tested and are now at the forefront to combat the effects of SARS-CoV-2 infection. This review article will discuss all kinds of ins and outs of SARS-CoV-2 and COVID-19, including the transmission method, how to prevent it, as well as various drugs and vaccines currently used in handling COVID-19.Keywords
This publication has 43 references indexed in Scilit:
- ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaquesPublished by Cold Spring Harbor Laboratory ,2020
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19The New England Journal of Medicine, 2020
- COVID-19: Disease, management, treatment, and social impactScience of The Total Environment, 2020
- Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the statusInfection, Genetics and Evolution, 2020
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host responseDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- Review and analysis of current responses to COVID-19 in Indonesia: Period of January to March 2020Progress in Disaster Science, 2020
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trialInternational Journal of Antimicrobial Agents, 2020
- Teicoplanin: an alternative drug for the treatment of COVID-19?International Journal of Antimicrobial Agents, 2020
- Origin and evolution of pathogenic coronavirusesNature Reviews Microbiology, 2018
- ApeironApeiron, 2011